Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

GMP Audit Findings

Aseptic Media Fill SOP Gaps: A Critical Threat to Sterile GMP Compliance

Posted on By

Aseptic Media Fill SOP Gaps: A Critical Threat to Sterile GMP Compliance Why Inadequate SOPs for Aseptic Media Fills Pose Serious GMP Compliance Risks Introduction to the Audit Finding 1. Aseptic Simulation Under Scrutiny Aseptic media fills simulate real manufacturing to validate sterile process integrity. Poor SOPs compromise this simulation’s validity. 2. Common Observation in…

Read More “Aseptic Media Fill SOP Gaps: A Critical Threat to Sterile GMP Compliance” »

Critical Operations, GMP Audit Findings

Filter Integrity Testing Lapses: A Critical GMP Compliance Concern

Posted on By

Filter Integrity Testing Lapses: A Critical GMP Compliance Concern Why Procedural Gaps in Filter Integrity Testing Jeopardize GMP Compliance in Sterile Facilities Introduction to the Audit Finding 1. Filter Integrity Is a GMP Critical Control Sterile filters are essential barriers against microbial contamination in pharmaceutical manufacturing. 2. Integrity Testing Confirms Sterility Assurance Integrity testing ensures…

Read More “Filter Integrity Testing Lapses: A Critical GMP Compliance Concern” »

Critical Operations, GMP Audit Findings

GMP Gap in Sterilization SOPs: Missing Pre-Cycle Load Checks Compromise Compliance

Posted on By

GMP Gap in Sterilization SOPs: Missing Pre-Cycle Load Checks Compromise Compliance How Missing Pre-Cycle Load Checks in Sterilization SOPs Endanger GMP Compliance Introduction to the Audit Finding 1. Critical GMP Function Sterilization ensures microbial inactivation. Missing pre-cycle checks jeopardize the entire aseptic chain. 2. Load Check Purpose Verifying load placement, type, and configuration ensures uniform…

Read More “GMP Gap in Sterilization SOPs: Missing Pre-Cycle Load Checks Compromise Compliance” »

Critical Operations, GMP Audit Findings

Missing Exposure Time in Equipment Sterilization SOPs: A Critical GMP Oversight

Posted on By

Missing Exposure Time in Equipment Sterilization SOPs: A Critical GMP Oversight How Undefined Exposure Time in Sterilization SOPs Puts GMP Compliance at Risk Introduction to the Audit Finding 1. Sterilization Depends on Time, Temperature, and Pressure Exposure time is a critical component of the sterilization equation, ensuring microbial kill levels are achieved. 2. SOPs Must…

Read More “Missing Exposure Time in Equipment Sterilization SOPs: A Critical GMP Oversight” »

Critical Operations, GMP Audit Findings

Visual Inspection SOP Failures in Injectables: Gaps in Manual Controls and GMP Compliance

Posted on By

Visual Inspection SOP Failures in Injectables: Gaps in Manual Controls and GMP Compliance Why SOP Gaps in Manual Visual Inspection of Injectables Trigger GMP Audit Findings Introduction to the Audit Finding 1. Importance of Visual Inspection Visual inspection is the final critical control to detect visible defects like particles, cracks, or volume variation. 2. Human…

Read More “Visual Inspection SOP Failures in Injectables: Gaps in Manual Controls and GMP Compliance” »

Critical Operations, GMP Audit Findings

SOPs Not Aligned with Updated Annex 1 Requirements: A GMP Compliance Gap

Posted on By

SOPs Not Aligned with Updated Annex 1 Requirements: A GMP Compliance Gap Impact of Unaligned SOPs with Revised EU GMP Annex 1 on Regulatory Compliance Introduction to the Audit Finding 1. Annex 1 Revision: A Paradigm Shift The revised EU GMP Annex 1, effective August 2023, introduced key changes to sterile manufacturing expectations. 2. SOP…

Read More “SOPs Not Aligned with Updated Annex 1 Requirements: A GMP Compliance Gap” »

GMP Audit Findings, Regulatory Change

No Documented SOP Assessment Post Regulatory Updates: A Major GMP Oversight

Posted on By

No Documented SOP Assessment Post Regulatory Updates: A Major GMP Oversight GMP Risks of Skipping SOP Assessments After Regulatory Changes Introduction to the Audit Finding 1. Regulatory Changes Are Constant Health authorities worldwide frequently revise GMP standards, including FDA, EMA, WHO, and CDSCO updates. 2. SOPs Must Stay Current Every regulatory update should trigger a…

Read More “No Documented SOP Assessment Post Regulatory Updates: A Major GMP Oversight” »

GMP Audit Findings, Regulatory Change

Risks of Using Outdated SOPs Post Regulatory Change in Pharma

Posted on By

Risks of Using Outdated SOPs Post Regulatory Change in Pharma Regulatory Compliance Risks of Continuing SOP Use After Regulation Changes Introduction to the Audit Finding 1. SOPs Must Reflect Current Regulations Using outdated procedures after a change in pharmaceutical regulations is a common but serious GMP violation. 2. Regulatory Expectations Are Dynamic Regulatory bodies like…

Read More “Risks of Using Outdated SOPs Post Regulatory Change in Pharma” »

GMP Audit Findings, Regulatory Change

Failure to Update Sampling Plans as per Revised WHO GMP Annexes

Posted on By

Failure to Update Sampling Plans as per Revised WHO GMP Annexes Why Ignoring WHO Annex Updates in Sampling Plans Triggers GMP Audit Findings Introduction to the Audit Finding 1. Regulatory-Driven Change Is Non-Negotiable Failure to revise sampling plans in line with updated WHO GMP Annexes is a critical regulatory compliance lapse. 2. Updated Annexes Demand…

Read More “Failure to Update Sampling Plans as per Revised WHO GMP Annexes” »

GMP Audit Findings, Regulatory Change

SOPs Reference Withdrawn Regulatory Guidance Documents — A Hidden Compliance Trap

Posted on By

SOPs Reference Withdrawn Regulatory Guidance Documents — A Hidden Compliance Trap When SOPs Cite Withdrawn Guidance: A Regulatory Red Flag in Pharma Introduction to the Audit Finding 1. Regulatory References Must Be Current SOPs that refer to withdrawn or outdated regulatory documents fail to ensure ongoing GMP compliance. 2. Obsolete Guidelines Invalidate SOP Content When…

Read More “SOPs Reference Withdrawn Regulatory Guidance Documents — A Hidden Compliance Trap” »

GMP Audit Findings, Regulatory Change

Posts pagination

Previous 1 … 5 6 7 … 12 Next

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme